Postherpetic neuralgia and recalcitrant cystic lesions following herpes zoster: A case report and review of treatment options.
cystic lesions
herpes zoster
postherpetic neuralgia
treatment-resistant
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
17
03
2020
revised:
05
04
2020
accepted:
04
06
2020
pubmed:
9
6
2020
medline:
15
5
2021
entrez:
9
6
2020
Statut:
ppublish
Résumé
Acute herpes zoster lesions in most cases are self-limited except in older and immunocompromised patients, wherein the pain can cause significant suffering. Postherpetic neuralgia is a painful situation for patients that can compromise the quality of life. Here, we report a 30-year-old healthy young man who developed treatment-resistant postherpetic neuralgia after herpes zoster (fourth/fifth thoracic segment) without any underlying immunocompromised state. He also developed some cystic lesions, which were removed by aspiration and surgery. The skin lesions improved 2 weeks after the surgery and postherpetic neuralgia was completely cured after 5 months, however cystic lesions recurred multiple times and were excised completely during each visit. Postherpetic neuralgia has a significant impact on the health-care cost borne by the society and affected individual, hence, it is essential to select appropriate treatment to manage the pain of postherpetic neuralgia.
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13793Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Hu Y, Zou L, Qi X, et al. Subcutaneous botulinum toxin-a injection for treating postherpetic neuralgia. Dermatol Ther. 2020 Jan;33(1):e13181.
Lee EJ, Yoon YJ. A case of generalized varicelliform eruption after herpes zoster oticus. Otol Neurotol. 2014;35(1):e57-e59.
Shenefelt PD. Biofeedback, cognitive-behavioral methods, and hypnosis in dermatology: is it all in your mind? Dermatol Ther. 2003;16(2):114-122.
Stankus SJ, Dlugopolski M, Packer D. Management of herpes zoster (shingles) and postherpetic neuralgia. Am Fam Physician. 2000;61(8):2437-44-2447-8.
Acosta EP, Balfour HH. Acyclovir for treatment of postherpetic neuralgia: efficacy and pharmacokinetics. Antimicrob Agents Chemother. 2001;45(10):2771-2774.
Chen CJ, Yu HS. Acupuncture, electrostimulation, and reflex therapy in dermatology. Dermatol Ther. 2003;16(2):87-92.
Creed R, Satyaprakash A, Ravanfar P. Varicella zoster vaccines. Dermatol Ther. 2009;22(2):143-149.
Johnson RW, Dworkin RH. Treatment of herpes zoster and postherpetic neuralgia. BMJ. 2003;326(7392):748-750.
Hadley GR, Gayle JA, Ripoll J, et al. Post-herpetic neuralgia: a review. Curr Pain Headache Rep. 2016;20(3):17.
Weinberg JM, Scheinfeld NS. Cutaneous infections in the elderly: diagnosis and management. Dermatol Ther. 2003;16(3):195-205.
Mueller NH, Gilden DH, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin. 2008;26(3):675-697.
Amjadi O, Rafiei A, Haghshenas M, et al. A systematic review and meta-analysis of seroprevalence of varicella zoster virus: a nationwide population-based study. J Clin Virol. 2017;87:49-59.
Irwin M, Pike J, Oxman M. Shingles immunity and health functioning in the elderly: Tai Chi Chih as a behavioral treatment. Evid Based Complement Alternat Med. 2004;1(3):223-232.
Saguil A, Kane S, Mercado M, Lauters R. Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Physician. 2017;96(10):656-663.
Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc. 2009;84(3):274-280.
Lu W-H, Lin C-W, Wang C-Y, Chen L-K, Hsiao F-Y. Epidemiology and long-term disease burden of herpes zoster and postherpetic neuralgia in Taiwan: a population-based, propensity score-matched cohort study. BMC Public Health. 2018;18(1):369.
Mallick-Searle T, Snodgrass B, Brant JM. Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology. J Multidiscip Healthc. 2016;9:447-454.
Argoff CE. Review of current guidelines on the care of postherpetic neuralgia. Postgrad Med. 2011;123(5):134-142.
Fashner J, Bell AL. Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Physician. 2011;83(12):1432-1437.
Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162-173.
Nalamachu S, Morley-Forster P. Diagnosing and managing postherpetic neuralgia. Drugs Aging. 2012;29(11):863-869.
Welsby PD. Chickenpox, chickenpox vaccination, and shingles. Postgrad Med J. 2006;82(967):351-352.
Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132(3):237-251.
Dworkin RH, O'Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(suppl 3):S3-S14.
Kantor D, Panchal S, Patel V, Bucior I, Rauck R. Treatment of postherpetic neuralgia with gastroretentive gabapentin: interaction of patient demographics, disease characteristics, and efficacy outcomes. J Pain. 2015;16(12):1300-1311.
Sang CN, Sathyanarayana R, Sweeney M. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN). Clin J Pain. 2013;29(4):281-288.
Lee EG, Lee HJ, Hyun DJ, Min K, Kim DH, Yoon MS. Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study. Dermatol Ther. 2016;29(3):184-190.
Derry S, Sven-Rice A, Cole P, Tan T, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2013;2:CD007393.
Casale R, di Matteo M, Minella CE, Fanelli G, Allegri M. Reduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case series. J Pain Res. 2014;7:353-357.
Bajwa ZH, Ortega E. Postherpetic Neuralgia: Up-to-Date. US: Up-to-Date; 2018.
Halb L, Amann BJ, Bornemann-Cimenti H. Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia. Nervenarzt. 2017;88(4):408-414.
Knapp DJ. Postherpetic neuralgia: case study of class 4 laser therapy intervention. Clin J Pain. 2013;29(10):e6-e9.
Kim YH, Lee PB, Oh TK. Is magnesium sulfate effective for pain in chronic postherpetic neuralgia patients comparing with ketamine infusion therapy? J Clin Anesth. 2015;27(4):296-300.
Pickering G, Morel V. Memantine for the treatment of general neuropathic pain: a narrative review. Fundam Clin Pharmacol. 2018;32(1):4-13.
Kuo YC, Hsieh LF, Chiou HJ. Ultrasound-guided musculocutaneous nerve block in postherpetic neuralgia. Am J Phys Med Rehabil. 2016;95(1):e1-e6.